SecBot SecBot
SC 13G ·Filed Nov 13, 2026

AEON

AEON Biopharma, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed3d 7h ago SEC0001104659-26-127174
Passive investor 5%+ stake
Actionable Insight • Neutral

Nantahala's 9.99% passive stake is just below the 10% threshold that triggers additional disclosure and trading restrictions. The inclusion of convertible securities suggests potential for further economic exposure. Monitor for any amendment or conversion to SC 13D if Nantahala's intent changes.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Nantahala Capital Management, LLC disclosed a 9.99% passive beneficial ownership stake in AEON Biopharma as of September 30, 2026, holding 5,048,027 shares (including 648,027 shares from convertible securities). This is a new filing by Nantahala; the prior SC 13G was filed by Timothy P. Lynch, a different reporting person.

Key Financial Metrics

Stake
9.99%
Investor
Nantahala Capital Management, LLC
Investor Type
hedge fund

Key Facts

  • Nantahala Capital Management, LLC filed a Schedule 13G disclosing beneficial ownership of 5,048,027 shares of AEON Biopharma Class A common stock.
  • The stake represents 9.99% of shares outstanding as of September 30, 2026.
  • The 5,048,027 shares include 648,027 shares that may be acquired within 60 days through exercise of convertible securities.
  • The filing certifies passive intent under Rule 13d-1(b) with no purpose of changing or influencing control.
  • Wilmot B. Harkey and Daniel Mack, as managing members of Nantahala, are also each reported as beneficial owners of the same 9.99% stake.
  • The prior SC 13G (filed August 21, 2026) was by Timothy P. Lynch, not Nantahala, so this is a new reporting person.

Financial Impact

9.99% stake in a company with a $12M market cap implies a position value of approximately $1.2M at the snapshot price.

ownership concentration

Risk Factors

  • A 9.99% stake near the 10% threshold may invite regulatory scrutiny or signal potential future activism.
  • The company's small $12M market cap makes this a concentrated position, increasing volatility risk from any change in Nantahala's holdings.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001104659-26-127174
Document: 0001104659-26-127174-index.html0001104659-26-127174
Document: 0001104659-26-127174.txt0001104659-26-127174

Track record

22 reports on AEON

Performance horizon

8 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +44.50% at T+60 after the Jul 9, 2026 report. 9 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.1600 Now $0.1410 −11.87% settles Nov 24
  2. Nov 16, 2026today Press Release Neutral 5/10 Entry $0.1410 Now $0.1410 +0.00% settles Nov 24
  3. Nov 13, 20263d ago SC 13G Neutral 4/10 Viewing Entry $0.1610 Now $0.1410 −12.42% settles Nov 23
  4. Nov 10, 20266d ago SC 13D/A Neutral 3/10 Entry $0.1793 Now $0.1410 −21.36% settles Nov 17
  5. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $0.1818 to $0.1407 Now $0.1410 −22.44% ▼ −22.61% −20.91% vs SPY
  6. Nov 3, 202613d ago 8-K Neutral 4/10 Entry $0.2122 to $0.1793 Now $0.1410 −33.55% ▼ −15.50% −14.92% vs SPY
  7. Oct 26, 202621d ago DEF 14A Neutral 3/10 Entry $0.2483 to $0.2122 Now $0.1410 −43.21% ▼ −14.54% −12.55% vs SPY
  8. Oct 23, 202624d ago 8-K Neutral 4/10 Entry $0.2400 to $0.2740 Now $0.1410 −41.25% ▲ +14.17% +15.43% vs SPY
  9. Sep 30, 20266w ago 8-K Bullish 7/10 Entry $0.3000 to $0.3110 Now $0.1410 −53.00% ▲ +3.67% +1.75% vs SPY
  10. Aug 21, 202612w ago 3 Neutral Not scored Entry $0.1974 to $0.2959 Now $0.1410 −28.57% ▲ +49.90% +49.43% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens in 8h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026